BACKGROUND: Guidelines for treating overweight and obesity have been suggested by the World Health Organization and other expert groups. We asked whether most men and women targeted in obesity guidelines would already be included in existing clinical recommendations for the prevention of coronary heart disease (CHD) or whether a new group of patients would be added to current workloads. SUBJECTS AND METHODS: In 1997 the Norwegian National Health Screening Service examined CHD risk factors in subjects aged 40 -42 y living in three counties. We studied 6911 men and 7992 women who did not report treatment for diabetes, hypertension or the presence of cardiovascular disease. Estimated 10 y risk of CHD was calculated using the Framingham equation. RESULTS: The prevalence of single risk factors (systolic blood pressure 160 mmHg, diastolic blood pressure 95 mmHg, total cholesterol level 7.8 mmol=l and nonfasting glucose 11.1 mmol=l) ranged between 0 and 11% among subjects with body mass index 25 kg=m 2 . Adding low HDL cholesterol (<1.0 mmol=l for men, <1.1 mmol=l for women) and 10 y risk CHD risk to the classical risk factors increased prevalence to 16 -50% (one or more risk factors or 10 y risk 10%). Sensitivities and specificities of using body mass index (BMI) or BMI and waist circumference as a screen for elevated CHD risk ranged between 22 and 91%. Screening for 10 y CHD risk of 10% or one or more risk factors among men and screening for one or more risk factors among women gave positive predictive values of 19 -50%; however, the positive predictive value of screening for 10 y CHD risk of 10% was only 1 -2% among women. Compared with men with BMI<30 kg=m 2 or waist circumference <102 cm, those with measurements equal to or above these levels had statistically significantly higher adjusted odds ratios of elevated CHD risk (1.49, 95% CI 1.24 -1.79 and 1.48, 95% CI 1.22 -1.80, respectively); these associations were not observed among women. CONCLUSION: Using BMI and waist circumference to screen for CHD risk yields low positive prediction values, thus doubling the number of men and adding even more to the number of women seen by the practitioner for prevention of CHD.
Introduction
Obesity is a growing epidemic in most of the world's populations. 1, 2 Increasing adiposity, particularly central adiposity, contributes to a rise in the incidence of coronary heart disease (CHD) through lipid and glucose abnormalities, elevated blood pressure and other factors. 2 In Norway, mean body weight and the prevalence of obesity, defined as body mass index (BMI) 30 kg=m 2 , has increased steadily since 1980. 3 Guidelines for treating overweight (BMI 25 -29.9 kg=m 2 ) and obesity have been suggested by the World Health Organization and European and North American expert groups. 2 -6 The guidelines recommend weight loss for men and women with BMI 25 -30 kg=m 2 and CHD risk factors or BMI 30 kg=m 2 (Table 1) . While providing a logical management process for treating overweight and obesity, the guidelines have not been tested in practice, 4 even though large segments of the population may be in need of treatment.
The targets of these guidelines are practising doctors; however, the same doctors are asked to follow guidelines for prevention of CHD. 7 The joint guidelines of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension suggest estimation of total CHD risk based on gender, age, blood pressure, total cholesterol level and cigarette smoking. 7 Men and women who have a 10% risk of developing CHD in the next 10 y are considered to be at moderate risk and risks of >20% are considered high. In addition, practitioners are expected to treat patients with CHD risk factors, including dyslipidemia, hypertension and diabetes, regardless of total CHD risk, as defined by national or international guidelines and usual clinical practice. However, studies suggest that practitioners lack time or ability to consistently diagnose and treat CHD risk factors, excepting patients with established disease, 8 -10 and even when encouraged to do so by support procedures. 11 Implementation of guidelines for obesity and overweight may be further limited, unless the physician already sees many of the overweight and obese persons for CHD prevention and treatment of established risk factors.
In the current study we asked whether targeting 40 to 42-y-old men and women for treatment of obesity and overweight would add a large, new group of patients to physicians' workloads. We assessed risk of CHD both according to total CHD risk as recommended previously 7 and whether CHD risk factors that may require follow-up and treatment were present, including lipid abnormalities, high blood pressure or glucose levels. To assess regional fat distribution, we chose the waist circumference based on the relative ease with which waist circumference can be measured and the established relationship between waist circumference and CHD risk factors.
Subjects and methods
The National Health Screening Service invited all men and women aged 40 -42 y in three Norwegian countries (Akershus, Troms not including Tromsø City, and Finnmark) to take part in a health screening in 1996 -1997. Subjects attended mobile health units or community centers for anthropometric and blood pressure measurements as well as blood sampling. Persons who did not attend the first time were reminded twice. The attendance rate varied from 49 to 60% among men and 59 to 71% among women. There were 15 315 men and women aged 40 -42 y at the start of the screening program who were reportedly free of cardiovascular disease and had complete values for height, weight, waist circumference and laboratory parameters. Subjects treated for diabetes (n ¼ 134) or high blood pressure (n ¼ 278) were excluded. Thus, the study comprised 6911 men and 7992 women. Data on smoking status was missing for two subjects, physical activity data was missing for 69 subjects, and the family history was missing for 183 subjects.
The objectives and methods of screening have been described earlier. 12 Respondents filled out a questionnaire at home which surveyed civil status, medical history, health-related behaviors, and family history of myocardial infarction. Physical activity was defined according to four levels with the lowest being no or less than weekly activity leading to sweatiness or short-windedness, and the highest being training for competition or professional sports events, Action levels in obesity and coronary heart disease S Tonstad and S Graff-Iversen as an average during the past year. Level of education was assessed by six alternatives from not completing elementary school to university level. Anthropometric measurements were done with subjects wearing light clothes. Body weight was measured to the nearest 0.5 kg and height to the nearest centimeter. Waist circumference was measured once midway between the lowest rib and the iliac crest using a steel tape measure. Sitting blood pressures were measured three times after a 2 min rest using automatic sphygmomanometers (Dinamap).
The cuff was applied to the right upper arm with a standardized approach used to determine the size. Systolic and diastolic blood pressures were calculated as the average of the second and third of three consecutive measurements done at intervals of 1 min.
Laboratory measurements
A nonfasting blood sample was taken and analyzed for lipids and glucose. Total cholesterol, triglyceride and glucose concentrations were measured using automated analyzer equipment (Hitachi 911; Hitachi Limited, Tokyo, Japan) and reagents from Boehringer Mannheim, Germany. HDL cholesterol concentrations were measured on a Hitachi 911 analyzer using the direct, enzymatic inhibition assay of Boehringer Mannheim. All analyses were performed at the Department of Clinical Chemistry, Ullevål University Hospital, Oslo, Norway.
Analysis
The National Health Screening Service referred subjects exceeding predetermined action levels of cholesterol or systolic or diastolic blood pressure to their primary care physician for reexamination. In the current study, we used similar, internationally defined cut-off levels and defined hypertension as systolic blood pressure 160 mmHg or diastolic blood pressure 95 mmHg. 13 Serum cholesterol concentration 7.8 mmol=l was considered elevated.
14 Low HDL cholesterol was defined as <1.0 mmol=l for men and <1.1 mmol=l for women. 7 Increased nonfasting glucose levels were defined as 11.1 mmol=l. 15 Cut-off or action levels for BMI were 25 -29.9 kg=m 2 or 30 kg=m 2 , as suggested previously. 2 For waist circumference these levels were 94 -101 cm and 102 cm, respectively, for men, and 80 -87 cm and 88 cm, respectively, for women. 2, 16 Because Scandinavian guidelines use waist circumference to stratify risk in overweight subjects, 5 we also considered action levels of BMI of 30 kg=m 2 or 25 -29.9 kg=m 2 with waist 94 cm (men) and BMI 30 kg=m 2 or 25 -29.9 kg=m 2 with waist 88 cm (women).
The estimated 10 y incidence of CHD (total CHD risk) was calculated for each subject by entering into the equations of the Framingham risk model the following variables: age, gender, systolic blood pressure, total and HDL cholesterol, and current smoking status. 17 The Framingham model allows the risk estimation of individuals aged 30 -74 y over a 12 y period. The original model includes the presence or absence of left ventricular hypertrophy, when known. In the current analysis, information on left ventricular hypertrophy was not known.
Statistical methods
Sensitivity was the percentage of subjects with one or more CHD risk factors and=or 10 y CHD risk 10% who were identified correctly by high BMI or waist circumference. Specificity was the percentage of subjects without one or more CHD risk factors and=or 10 y CHD risk 10% who were identified correctly by low BMI or waist circumference. Positive predictive value was the percentage of subjects with high BMI or waist circumference who had increased risk, as defined above, and negative predictive value was the percentage of subjects with a low BMI or waist circumference who did not have elevated risk. Confidence intervals were calculated using the standard error for percentages: the square root of P (100 7 P)=n, where P represents one percentage, (100 7 P) represents the other, and n is the number of subjects. These analyses were performed separately for each gender. Logistic regression analysis was employed among men and women separately to determine the relative risk of the prevalence of an elevated 10 y risk of CHD ( 10%) in subjects categorized by BMI <30 or 30 kg=m 2 and by waist circumference <102 or >102 cm (men) or <88 or 88 cm (women). We wished to examine the association between total CHD risk and BMI or waist circumference independently of known risk factors. Thus, we adjusted for physical activity, educational level, serum triglycerides and glucose and presence of a positive family history of CHD before age 60 y but not for variables already included in the Framingham risk equation. Data analysis was performed using the statistical package SPSS 9.0 (SPSS Inc., Chicago, IL).
Results
The subjects were mostly married and had >10 y of education (Table 2) . Mean BMI and waist circumference were higher among men than women. Most CHD risk factor levels, including a positive family history of myocardial infarction, increased monotonously with increasing BMI among men and women, as did estimated 10 y rate of CHD Action levels in obesity and coronary heart disease S Tonstad and S Graff-Iversen (Table 3 ). The exception was cigarette smoking, which was more prevalent in thinner subjects (Table 3) . These findings were similar for CHD risk factor levels considered according to waist circumference (data not shown). The prevalences of elevated systolic blood pressure, elevated diastolic blood pressure, high total cholesterol level, and high nonfasting glucose were 0.1 -6.3% and 0 -2.7% in men and women, respectively, with BMI 25 -29.9 kg=m 2 , and 0.6 -11.2% and 0.5 -6.2% in men and women, respectively, with BMI 30 kg=m 2 (Table 4) . When HDL cholesterol and 10 y rate of CHD were considered, 15.8 and 31.5% of overweight women and men, respectively, and 31.5 and 49.9% of obese women and men, respectively, had elevated risk (Table  4) . These findings were similar using cut-off levels for waist circumference (data not shown). Among women, prevalence of estimated 10 y CHD risk 10% was low and appeared to be entirely accounted for by known risk factors with values beyond cut-off levels (Table 4) .
Sensitivities and specificities for identifying CHD risk from BMI at various action levels of BMI or BMI combined with waist circumference were in the range of 22 -91% for men (Table 5 ) and 23 -91% for women (Table 6 ). Among men, the positive predictive values varied from 19 to 50%, and negative predictive values varied from 74 to 92% (Table 5 ). Among women, positive predictive values were lower than among men, and ranged from 19 to 28% for identifying one or more CHD risk factors or 10 y rate of CHD; when only 10 y rate of CHD was considered positive predictive values were 0.9 -1.6% (Table 6 ). Negative predictive values were very high among women (90 -99.9%).
The relative risk of elevated risk of CHD ( 10%) identified by using odds ratios adjusted for educational level, physical activity, serum triglyceride and glucose levels and presence of a positive family history of myocardial infarction before age 60 y compared to a BMI <30 kg=m 2 or to a waist circumference <102 cm (men) or <88 cm (women) was increased in men (1.49, 95% CI 1.24 -1.79) but not in women (0.74, 95% CI 0.30 -1.79) with a BMI 30 kg=m 2 or a waist circumference above the action levels (odds ratio (6) 105. (7) 74. (6) 83. (7) 98. (9 129. (14) 134. (14) 140. (14) 121. (12) 126. (13) Action levels in obesity and coronary heart disease S Tonstad and S Graff-Iversen among men 1.48, 95% CI 1.22 -1.80; odds ratio among women 1.78, 95% CI 0.80 -4.00).
Discussion
Guidelines suggest that obese men and women (BMI 30 kg=m 2 ) with or without CHD risk factors and overweight men and women (BMI 25 -29.9 kg=m 2 ) with CHD risk factors should be treated. Most of the overweight men and women in our study did not have a classic CHD risk factor. However, when HDL cholesterol concentration was considered either alone or as a contributor to estimated 10 y CHD risk, almost one-third of men and one-sixth of women carried elevated risk. Among obese subjects, one-half of men and over one-quarter of women had elevated risk.
Screening for the presence of either elevated total CHD risk or CHD risk factors using action levels for overweight and obesity yielded positive predictive values that approached 50% (35 -50%) among men. However, because of the low 10 y CHD rate among women aged 40 -42 y, positive predictive values were low (19 -28%). Thus, adding obesity treatment to usual CHD prevention increases substantially the number of men and even more the number of women that require follow-up according to current guidelines for obesity treatment (Table 1) . In older age groups, when the risk of CHD in women increases, smaller differences between the sexes may be expected. Elevated BMI or waist circumference was independently associated with estimated 10 y risk of CHD among men, but not among women.
Previous analyses by Han et al 16 showed higher positive prediction values among women than the present study, however, the analysis included a broader age range, from 20 to 59 y. Furthermore, total CHD risk was not considered. Megnien et al reported significant associations between waist-to-hip ratio and CHD risk using several models, but did not compute predictive values. 18 Among both men and women, using BMI >30 kg=m 2 or the combination of BMI 25 -29.9 kg=m 2 and waist measurements yielded sensitivities and specificities that were greater than 50%, in contrast to sensitivities that were below 50% obtained when using only BMI >30 kg=m 2 and specificities <50% when the cut-off point for BMI was 25 kg=m 2 . These findings suggest that measuring both BMI and waist circumference may be necessary when considering CHD risk, in accordance with the biological association between abdominal fat and CHD risk.
Testing for total CHD risk requires assessment of all the risk factors. However, none of the current guidelines for the prevention of CHD, including those issued by the European Task Force, 7 the International Task Force, 19 the Joint British groups, 20 or the National Cholesterol Education Program 21 include BMI or waist circumference as a Action levels in obesity and coronary heart disease S Tonstad and S Graff-Iversen factor required to estimate CHD risk, although all of these guidelines underscore the importance of weight reduction for overweight and obese individuals. This approach may be based on the notion that the risk associated with increased BMI is completely accounted for by factors contained in the various risk algorithms, as shown in the Münster Heart Study. 22 Other long-term longitudinal studies, including the Framingham, the Nurses' Health and Finnish studies have demonstrated that obesity has a direct impact on the incidence of cardiovascular disease, even after correction for other risk factors. 23 -25 Some authors have argued that whether or not obesity has a residual effect on cardiovascular disease beyond risk factors is not very important in health practice. 25 However, we suggest that in view of the low 10 y rate of CHD among women aged 40 -42 y, treatment of obesity in this group with the sole aim of CHD prevention may not be warranted. Although for many premenopausal women, the adverse effects of obesity may take several decades to become manifest and obesity increases risk of other diseases than CHD, obesity treatment has shown only short-term effects on body weight and most CHD risk factors. 26, 27 Moreover, effective treatments are currently available for other risk factors for CHD. Paradoxically, most weight control programs and clinical trials predominantly attract women, 28 furthermore, substantial numbers of men whose BMI places them at increased health risk are not attempting to reduce body weight. 29 There are several limitations that should be considered when examining the results of this study. Subjects with known diabetes, cardiovascular disease or high blood pressure were excluded from the study. This implies that the likelihood of observing associations between obesity and risk factors is reduced. However, we wished to estimate the test characteristics for BMI or waist circumference measurements in subjects who were not already being treated for CHD or major CHD risk factors. A further limitation is that estimation of risk was based on an equation developed in the Framingham population. However, the joint risk guidelines issued by the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension for use in practice are based on this equation. Moreover, the Framingham risk estimates appear to be valid for northern European populations. 30 A third limitation is our choice of cut-off levels for CHD risk factors. Although our results may have differed if other levels were chosen, we based our analysis on conservative levels that most physicians would consider to be high risk levels. 13 -15 In conclusion, low positive predictive values of obesity as a screen for estimated 10 y CHD risk in women aged 40 -42 y suggest that a large number of women will require treatment and follow-up if such screening is implemented. While most CHD risk factors are easily identifiable, many physicians do not appear to implement clinical guidelines for treatment of dyslipidemia, hypertension or diabetes mellitus, 9 -11 recently, similar results have been reported for overweight and obesity. 31 We suggest that in the age group that we have examined, men should be prioritized for obesity awareness and treatment.
